View ValuationRyan Specialty Holdings 향후 성장Future 기준 점검 4/6Ryan Specialty Holdings (는) 각각 연간 46.9% 및 7.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 27.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 88.6% 로 예상됩니다.핵심 정보46.9%이익 성장률27.70%EPS 성장률Insurance 이익 성장2.0%매출 성장률7.8%향후 자기자본이익률88.64%애널리스트 커버리지Good마지막 업데이트21 May 2026최근 향후 성장 업데이트Major Estimate Revision • May 11Consensus EPS estimates fall by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.36b to US$3.26b. EPS estimate also fell from US$1.00 per share to US$0.831 per share. Net income forecast to grow 162% next year vs 3.0% growth forecast for Insurance industry in the US. Consensus price target down from US$48.59 to US$42.88. Share price rose 5.6% to US$31.31 over the past week.Price Target Changed • Apr 10Price target decreased by 7.3% to US$49.65Down from US$53.53, the current price target is an average from 17 analysts. New target price is 44% above last closing price of US$34.57. Stock is down 53% over the past year. The company is forecast to post earnings per share of US$1.00 for next year compared to US$0.50 last year.Major Estimate Revision • Apr 09Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.44b to US$3.39b. EPS estimate also fell from US$1.12 per share to US$1.01 per share. Net income forecast to grow 387% next year vs 3.7% growth forecast for Insurance industry in the US. Consensus price target down from US$53.53 to US$50.35. Share price rose 4.1% to US$34.89 over the past week.Major Estimate Revision • Feb 20Consensus EPS estimates increase by 11%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from US$3.58b to US$3.46b. EPS estimate rose from US$1.02 to US$1.12. Net income forecast to grow 428% next year vs 9.7% growth forecast for Insurance industry in the US. Consensus price target down from US$64.31 to US$57.25. Share price fell 6.9% to US$41.33 over the past week.Price Target Changed • Feb 13Price target decreased by 10.0% to US$58.25Down from US$64.69, the current price target is an average from 16 analysts. New target price is 50% above last closing price of US$38.71. Stock is down 44% over the past year. The company is forecast to post earnings per share of US$0.83 for next year compared to US$0.50 last year.Major Estimate Revision • Nov 06Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.69 to US$0.766. Revenue forecast steady at US$3.08b. Net income forecast to grow 319% next year vs 9.9% growth forecast for Insurance industry in the US. Consensus price target down from US$72.00 to US$68.31. Share price rose 12% to US$56.94 over the past week.모든 업데이트 보기Recent updates속보 • 5hRyan Specialty Holdings Investigated for Securities Fraud After Revenue Slowdown and Stock DropPomerantz LLP has opened an investigation into Ryan Specialty Holdings and certain executives over potential securities fraud and unlawful business practices following its 2025 results. The probe is tied to disclosures of slower fourth-quarter organic revenue growth, lower profit margins versus the prior year, a cautious 2026 outlook, and a stock drop of nearly 13%. Cooper Investors highlighted Ryan Specialty as a key detractor in its first-quarter 2026 fund commentary, citing a weakening insurance pricing environment and a rapidly shifting insurance cycle, especially in property insurance. Taken together, the legal scrutiny and tougher insurance pricing backdrop point to higher near-term uncertainty around earnings quality, growth durability, and management’s communication with the market. Investors may want to track the progress of the Pomerantz investigation and how management addresses the changing insurance cycle, particularly its continued investment in talent and technology during a softer pricing phase.Major Estimate Revision • May 11Consensus EPS estimates fall by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.36b to US$3.26b. EPS estimate also fell from US$1.00 per share to US$0.831 per share. Net income forecast to grow 162% next year vs 3.0% growth forecast for Insurance industry in the US. Consensus price target down from US$48.59 to US$42.88. Share price rose 5.6% to US$31.31 over the past week.Declared Dividend • May 04First quarter dividend of US$0.13 announcedShareholders will receive a dividend of US$0.13. Ex-date: 12th May 2026 Payment date: 26th May 2026 Dividend yield will be 1.6%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (25% cash payout ratio). The dividend has increased by an average of 8.7% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 185% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • May 02Ryan Specialty Holdings, Inc. announces Quarterly dividend, payable on May 26, 2026Ryan Specialty Holdings, Inc. announced Quarterly dividend of USD 0.1300 per share payable on May 26, 2026, ex-date on May 12, 2026 and record date on May 12, 2026.Reported Earnings • May 01First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2026 results: EPS: US$0.14 (up from US$0.22 loss in 1Q 2025). Revenue: US$795.2m (up 18% from 1Q 2025). Net income: US$40.6m (up US$68.2m from 1Q 2025). Profit margin: 5.1% (up from net loss in 1Q 2025). Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 14%. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 10% per year.내러티브 업데이트 • Apr 29RYAN: AI Productivity And M&A Pipeline Are Expected To Sustain EarningsAnalysts have reduced the fair value estimate for Ryan Specialty Holdings from about $80.34 to $69.03. This reflects updated assumptions for slower revenue growth, slightly softer margins, and a modestly higher discount rate following a series of price target cuts across the Street.내러티브 업데이트 • Apr 14RYAN: AI Risk Repricing Will Meet Capital Returns And M&A ExecutionRyan Specialty Holdings' analyst price target has been revised lower to $36 from $43, as analysts incorporate more cautious assumptions on revenue growth, profit margins, and future P/E multiples following a broad series of recent target cuts across the broker group. Analyst Commentary Recent research points to a clear shift toward more cautious assumptions on Ryan Specialty Holdings, with several firms trimming price targets and at least one downgrade reflecting concern around growth durability, margins, and valuation support.Price Target Changed • Apr 10Price target decreased by 7.3% to US$49.65Down from US$53.53, the current price target is an average from 17 analysts. New target price is 44% above last closing price of US$34.57. Stock is down 53% over the past year. The company is forecast to post earnings per share of US$1.00 for next year compared to US$0.50 last year.Major Estimate Revision • Apr 09Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.44b to US$3.39b. EPS estimate also fell from US$1.12 per share to US$1.01 per share. Net income forecast to grow 387% next year vs 3.7% growth forecast for Insurance industry in the US. Consensus price target down from US$53.53 to US$50.35. Share price rose 4.1% to US$34.89 over the past week.공시 • Apr 07Ryan Specialty Holdings, Inc. to Report Q1, 2026 Results on Apr 30, 2026Ryan Specialty Holdings, Inc. announced that they will report Q1, 2026 results After-Market on Apr 30, 2026내러티브 업데이트 • Mar 31RYAN: AI Productivity And Capital Returns Will Support Future RepricingAnalysts have lowered price targets on Ryan Specialty Holdings by roughly $5 to $15 to reflect concerns about slower excess and surplus market growth and fears of AI-related disruption, even as some point to potential support from AI-driven productivity and margins that appear more resilient than recent trading suggests. Analyst Commentary Recent Street research on Ryan Specialty reflects a clear tilt toward more cautious views, with several firms cutting price targets and, in at least one case, lowering the stock rating.내러티브 업데이트 • Mar 17RYAN: Core Brokerage Role Will Benefit From AI Productivity TailwindThe updated analyst price target for Ryan Specialty Holdings edges up to $55.25 from $54.88, as analysts weigh softer revenue growth assumptions against slightly higher margin expectations and a modestly lower future P/E. They are also factoring in recent sector wide target cuts tied to AI disruption concerns and excess and surplus market deceleration.내러티브 업데이트 • Mar 03RYAN: Core Brokerage Role Will Withstand Softer P And C CycleAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings from about $66.53 to $54.88, reflecting lower Street price targets in the $43 to $65 range and updated expectations for slower revenue growth, softer profit margins, and a higher future P/E multiple. Analyst Commentary Recent Street research around Ryan Specialty Holdings has turned more cautious overall, with several firms cutting price targets and, in one case, lowering the rating.New Risk • Feb 25New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Payout ratio: 96% Dividend yield: 1.4% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Dividend is not well covered by earnings (96% payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).Recent Insider Transactions • Feb 25Director recently bought US$1.0m worth of stockOn the 23rd of February, Patrick Ryan bought around 26k shares on-market at roughly US$39.98 per share. This transaction amounted to 3.9% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold US$2.8m more in shares than they bought in the last 12 months.Major Estimate Revision • Feb 20Consensus EPS estimates increase by 11%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from US$3.58b to US$3.46b. EPS estimate rose from US$1.02 to US$1.12. Net income forecast to grow 428% next year vs 9.7% growth forecast for Insurance industry in the US. Consensus price target down from US$64.31 to US$57.25. Share price fell 6.9% to US$41.33 over the past week.내러티브 업데이트 • Feb 17RYAN: Softening P&C Cycle And Capital Moves Will Shape Future RepricingAnalysts have trimmed the fair value estimate for Ryan Specialty Holdings to $43 from $52, reflecting updated views on slower revenue growth assumptions, slightly lower profit margins, and a reduced future P/E multiple across recent Street research. Analyst Commentary Recent Street research on Ryan Specialty Holdings has shifted in a more cautious direction, with several bearish analysts trimming price targets and highlighting potential pressure on growth, margins, and valuation multiples.New Risk • Feb 16New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 3.9% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).Declared Dividend • Feb 16Fourth quarter dividend increased to US$0.13Dividend of US$0.13 is 8.3% higher than last year. Ex-date: 24th February 2026 Payment date: 10th March 2026 Dividend yield will be 1.3%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is not adequately covered by earnings (96% earnings payout ratio). However, it is well covered by cash flows (24% cash payout ratio). The dividend has increased by an average of 8.7% per year over the past 2 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 7.1% to bring the payout ratio under control. EPS is expected to grow by 173% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.New Risk • Feb 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Large one-off items impacting financial results.Price Target Changed • Feb 13Price target decreased by 10.0% to US$58.25Down from US$64.69, the current price target is an average from 16 analysts. New target price is 50% above last closing price of US$38.71. Stock is down 44% over the past year. The company is forecast to post earnings per share of US$0.83 for next year compared to US$0.50 last year.공시 • Feb 13+ 2 more updatesRyan Specialty Holdings, Inc., Annual General Meeting, Apr 28, 2026Ryan Specialty Holdings, Inc., Annual General Meeting, Apr 28, 2026.공시 • Feb 05Ryan Specialty Appoints Stephen Stewart as CEO of Ryan Specialty Canada LimitedRyan Specialty announced the appointment of Stephen Stewart, President & CEO of Stewart Specialty Risk Underwriting, a Ryan Specialty managing general underwriter, to the additional role Chief Executive Officer of Ryan Specialty Canada Limited, the newly formed Canadian operating and holding entity for Ryan Specialty’s underwriting management businesses in Canada. Ryan Specialty Canada Limited is headquartered in Toronto. In Stephen Stewart’s additional role as CEO of Ryan Specialty Canada Limited, he will lead the continued growth of Ryan Specialty’s Canadian platform while maintaining the underwriting discipline and specialist focus that have defined Stewart Specialty Risk Underwriting and Ryan Specialty’s other Canadian units. The legal integration is already underway, and teams are actively engaging with new colleagues across underwriting, operations, and support functions to build a unified Canadian platform.내러티브 업데이트 • Feb 03RYAN: Double Digit Organic Expansion Is Expected To Sustain Earnings Through Softer P&C CycleAnalysts now estimate Ryan Specialty Holdings' fair value at about $80.34, up from $76.00. This change reflects updated assumptions for slower revenue growth, lower profit margins, and a higher future P/E multiple across recent P&C insurance sector research.내러티브 업데이트 • Jan 19RYAN: Softening P&C Cycle And Governance Shift Will Shape Future Share RepricingAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings to $52 from $58, reflecting a lower future P/E assumption, while updated models still factor in steady revenue growth and margins across a softening property and casualty cycle. Analyst Commentary Recent Street research on Ryan Specialty presents a mixed picture, with several firms trimming price targets even as some maintain positive ratings.공시 • Jan 13Ryan Specialty Holdings, Inc. to Report Q4, 2025 Results on Feb 12, 2026Ryan Specialty Holdings, Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 12, 2026내러티브 업데이트 • Jan 05RYAN: Double Digit Organic Expansion Outlook Will Drive Future Share RepricingAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings to $58 from $60, reflecting updated views on revenue growth potential, profit margins, and a lower future P/E multiple after a mix of recent target cuts and raises across the Street. Analyst Commentary Recent Street research on Ryan Specialty Holdings shows a mix of optimism on the business model and caution on how much investors should be willing to pay for the stock.내러티브 업데이트 • Dec 18RYAN: Double Digit Organic Expansion Is Expected To Drive Strong Earnings AheadAnalysts have trimmed their price target for Ryan Specialty Holdings to $76 from $90, reflecting a modestly higher discount rate and more measured revenue growth expectations, even as they highlight resilient profit margins, double digit organic growth prospects into 2025 and 2026, and a still supportive earnings backdrop for property and casualty insurers. Analyst Commentary Bullish analysts acknowledge a reset in valuation assumptions but continue to frame Ryan Specialty as a long term compounder, citing durable organic growth, expanding distribution, and a supportive earnings environment for specialty focused intermediaries.Recent Insider Transactions Derivative • Dec 16CEO & Director exercised options and sold US$6.9m worth of stockOn the 12th of December, Timothy Turner exercised options to acquire 130k shares at no cost and sold these for an average price of US$53.61 per share. This trade did not impact their existing holding. For the year to December 2020, Timothy's total compensation was 20% salary and 80% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Timothy's direct individual holding has increased from 8.10k shares to 12.55k. Company insiders have collectively sold US$46m more than they bought, via options and on-market transactions in the last 12 months.공시 • Dec 09+ 1 more updateRyan Specialty Holdings, Inc. Announces Retirement of Bobby Le Blanc from Board of Directors, Effective February 11, 2026Ryan Specialty Holdings, Inc. announced that by mutual agreement following Onex Corporation’s sale of its remaining shares of Ryan Specialty, Bobby Le Blanc will retire from his service on the Ryan Specialty Board of Directors effective February 11, 2026. Mr. Le Blanc, Onex’ CEO, has served on Ryan Specialty’s Board since 2018, originally as Onex’ nominee with its investment in Ryan Specialty. Bobby Le Blanc contributed significantly to Ryan Specialty's growth and market leadership in specialty insurance solutions during his tenure on the board.내러티브 업데이트 • Dec 04RYAN: Double Digit Organic Expansion Will Outlast Softening Property And Casualty CycleAnalysts have trimmed their average price target on Ryan Specialty Holdings by about $2 to roughly $66.50. This reflects slightly lower assumptions for growth and margins amid softening property and casualty pricing, even as they continue to highlight the company's double digit organic revenue prospects and generally favorable long term earnings outlook.내러티브 업데이트 • Nov 20RYAN: Earnings Strength Will Overcome Sector Headwinds Into 2025Ryan Specialty Holdings' analyst price target saw a modest increase to $68.46, reflecting analyst expectations for slightly improved revenue growth and profit margins in light of resilient earnings and favorable industry conditions. Analyst Commentary Recent analyst coverage of Ryan Specialty Holdings reflects a nuanced perspective, with sentiment split between optimism about the firm's growth prospects and caution stemming from broader sector challenges.New Risk • Nov 07New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.1% Last year net profit margin: 4.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.1% net profit margin).Major Estimate Revision • Nov 06Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.69 to US$0.766. Revenue forecast steady at US$3.08b. Net income forecast to grow 319% next year vs 9.9% growth forecast for Insurance industry in the US. Consensus price target down from US$72.00 to US$68.31. Share price rose 12% to US$56.94 over the past week.내러티브 업데이트 • Nov 05RYAN: Ongoing Earnings Resilience And Sector Demand Will Drive Upside MomentumThe average analyst price target for Ryan Specialty Holdings has been revised downward by approximately $3.69 to $68.31. This reflects more cautious near-term assumptions on margin and sector growth trends, despite ongoing buy ratings and optimism around resilient earnings and organic growth.분석 기사 • Nov 03Ryan Specialty Holdings (NYSE:RYAN) Is Paying Out A Dividend Of $0.12The board of Ryan Specialty Holdings, Inc. ( NYSE:RYAN ) has announced that it will pay a dividend on the 25th of...Declared Dividend • Nov 03Third quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 10th November 2025 Payment date: 25th November 2025 Dividend yield will be 0.9%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (16% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 4.4% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 148% over the next 2 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Oct 31Third quarter 2025 earnings: EPS in line with analyst expectations despite revenue beatThird quarter 2025 results: EPS: US$0.49 (up from US$0.15 in 3Q 2024). Revenue: US$754.6m (up 28% from 3Q 2024). Net income: US$62.6m (up 249% from 3Q 2024). Profit margin: 8.3% (up from 3.1% in 3Q 2024). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.공시 • Oct 31+ 1 more updateRyan Specialty Holdings, Inc. Declares A Regular Quarterly Dividend, Payable on November 25, 2025On October 30, 2025, Ryan Specialty Holdings, Inc.’s board of directors declared a regular quarterly dividend of $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on November 25, 2025, to stockholders of record as of the close of business on November 11, 2025.내러티브 업데이트 • Oct 22Analysts Weigh Resilient Margins and Growth Outlook for Ryan Specialty Holdings Amid Valuation ShiftsAnalysts have slightly lowered their average price target for Ryan Specialty Holdings, noting resilient profit margins and earnings support from lighter catastrophe losses even as the sector faces growth headwinds. Analyst Commentary Recent Street research on Ryan Specialty Holdings highlights a mix of optimism and caution, reflecting varying outlooks for the company as growth moderates in the broader insurance sector.Major Estimate Revision • Oct 09Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.622 to US$0.693. Revenue forecast steady at US$3.07b. Net income forecast to grow 543% next year vs 13% growth forecast for Insurance industry in the US. Consensus price target broadly unchanged at US$71.85. Share price was steady at US$55.63 over the past week.공시 • Oct 09Ryan Specialty Holdings, Inc. Announces Executive ChangesOn October 8, 2025, the Board of Directors of Ryan Specialty Holdings, Inc. (the Company" or Ryan Specialty") appointed Stephen P. Keogh as Co-President and Chief Operating Officer and Brendan M. Mulshine as Co-President and Chief Revenue Officer of the Company to succeed Jeremiah Bickham as President, effective October 9, 2025. Stephen P. Keogh, age 59, has served as the Company's Chief Operating Officer since May 2025. Previously, Mr. Keogh was the Senior Advisor to the Office of President, Aon plc, a position he held from October 2021 until his retirement in September 2022. Prior to that, commencing June 2019, Mr. Keogh was President of Aon plc's Commercial Risk Solutions, the global risk management business of Aon. Mr. Keogh holds in excess of thirty-two years of experience at Aon, where he held positions in operations, finance and accounting, technology, human resources and executive management. Mr. Keogh earned a Bachelor's degree from the University of Illinois. Brendan M. Mulshine, age 59, has served as the Company's Executive Vice President and Chief Revenue Officer since 2020 and previously served as the Company's Executive Vice President and Managing Director from 2012 through 2020. From 1995 to 2012, Mr. Mulshine held various leadership positions at Aon Re, working with domestic and global insurance company clients on their reinsurance capital needs. Mr. Mulshine began his career practicing law in New York City. He earned a Bachelor of Arts from Yale College, a Juris Doctor from the University of Notre Dame School of Law, and a Master of Business Administration from Northwestern University's Kellogg School of Management. Changes to Messrs. On October 2, 2025, the Company and Mr. Jeremiah Bickham agreed that, effective October 8, 2025, Mr. Bickham would be transitioning from his role as President to serve as a non-employee strategic advisor to the Company through January 1, 2026.내러티브 업데이트 • Oct 08Emerging Risks And Data Analytics Will Expand Future OpportunitiesAnalysts have modestly reduced their price target for Ryan Specialty Holdings, citing commercial property growth headwinds and a slight decrease in projected revenue growth. The fair value estimate is now lowered by approximately $1.42 to $72.00 per share.공시 • Oct 03Ryan Specialty Holdings, Inc. to Report Q3, 2025 Results on Oct 30, 2025Ryan Specialty Holdings, Inc. announced that they will report Q3, 2025 results After-Market on Oct 30, 2025공시 • Sep 10Ryan Specialty Holdings, Inc. Appoints Michael G. Bungert to Its Board of Directors and Serves as A Member of Its Compensation and Governance Committee, Effective September 3, 2025Ryan Specialty Holdings, Inc. on September 3, 2025 elected Michael G. Bungert as a director and assigned him to its Compensation and Governance Committee, effective September 9, 2025. Mr. Bungert's initial term as a director will expire at the 2026 annual meeting of the Company's stockholders, at which time his continued Board service will be subject to renomination and stockholder approval. There are no transactions in which Mr. Bungert has or will have an interest that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K under the Exchange Act, at this time. The selection of Mr. Bungert was not pursuant to any arrangement or understanding between him and any other person. Mr. Bungert will participate in the Company's standard non-employee director compensation arrangements. Mr. Bungert will receive a grant of restricted stock units (RSUs) with a grant date fair value equal to $200,000 (prorated for the portion of the year for which he served as a director) that fully vest on the grant date and each RSU represents a right to receive one fully vested share of the Company's Class A common stock. The Company will make the annual equity grant of RSUs on the date of the Company's next annual meeting of stockholders and such grant will be compensation for the prior year of service, or portion thereof. Additionally, Mr. Bungert will be entitled to receive a cash payment in the amount of $120,000 per year, paid quarterly, in respect of his service as a member of the Board, with no additional cash compensation paid on account of his service on the Compensation and Governance Committee. Mr. Bungert has had a long and illustrious reinsurance career, most recently as Chairman of Aon Re Global from which he retired in 2024 after 11 years in that position. Prior to being Chairman, Mr. Bungert was CEO of Aon Re, a position he assumed in 1998. Mr. Bungert started his career in reinsurance in 1977 as an underwriter trainee at Continental Casualty Company. He then joined CNA Re in 1979 as a London-based North American underwriter. In 1984, Mr. Bungert joined reinsurance intermediary Thomas A. Greene Inc. Intermediaries in Chicago and subsequently joined Aon Re in 1989.내러티브 업데이트 • Sep 04Emerging Risks And Data Analytics Will Expand Future OpportunitiesAmid increased competition in personal auto, softened reinsurance pricing, and pressure on underwriting margins for carriers, analysts have adopted a more cautious outlook for the sector—though brokers like Ryan Specialty are expected to demonstrate relative earnings resilience—with the consensus price target remaining unchanged at $73.42. Analyst Commentary Increased competition in the personal auto insurance market and softened reinsurance pricing, resulting in a more cautious outlook and modest reductions of price targets.Major Estimate Revision • Aug 07Consensus EPS estimates fall by 14%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$0.853 to US$0.733 per share. Revenue forecast steady at US$3.08b. Net income forecast to grow 571% next year vs 11% growth forecast for Insurance industry in the US. Consensus price target down from US$78.00 to US$75.60. Share price fell 2.7% to US$59.55 over the past week.분석 기사 • Aug 04Ryan Specialty Holdings (NYSE:RYAN) Will Pay A Dividend Of $0.12Ryan Specialty Holdings, Inc. ( NYSE:RYAN ) has announced that it will pay a dividend of $0.12 per share on the 26th of...Declared Dividend • Aug 04Second quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 12th August 2025 Payment date: 26th August 2025 Dividend yield will be 0.8%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is not covered by earnings (233% earnings payout ratio). However, it is well covered by cash flows (25% cash payout ratio). The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years. The company's earnings per share (EPS) would need to grow by 159% to bring the payout ratio under control. EPS is expected to grow by 418% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.Reported Earnings • Aug 01Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2025 results: EPS: US$0.41 (up from US$0.38 in 2Q 2024). Revenue: US$855.2m (up 26% from 2Q 2024). Net income: US$124.7m (up 176% from 2Q 2024). Profit margin: 15% (up from 6.6% in 2Q 2024). Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) missed analyst estimates by 1.9%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.공시 • Aug 01+ 1 more updateRyan Specialty Holdings, Inc. Updates Earnings Guidance for the Full Year 2025Ryan Specialty Holdings, Inc. updated earnings guidance for the full year 2025. Organic Revenue Growth Rate guidance for full year 2025 is between 9.0% – 11.0%, compared to the company’s prior guidance of 11% – 13.0%.공시 • Jul 18Ryan Specialty Holdings, Inc. Announces Board and Committee ChangesRyan Specialty Holdings, Inc. shared the sad news of the loss of Director, D. Cameron (“Cam”) Findlay, who unexpectedly passed away earlier this month. Mr. Findlay served on the Ryan Specialty Board, including its pre-IPO predecessor, since 2012, and was most recently the chairperson of the Compensation and Governance Committee, a member of the Executive Committee, and the Board’s Lead Director. From 2013 until his retirement in 2023, Mr. Findlay was the Senior Vice President, General Counsel, and Secretary of Archer Daniels Midland Company. From 2009 to 2013, he was Senior Vice President and General Counsel of Medtronic, Inc., and from 2003 to 2009 he served as Executive Vice President and General Counsel of Aon Corporation. In addition to his time as a lawyer and businessperson, Mr. Findlay had a distinguished career in government service, including at the White House as deputy assistant to President George H.W. Bush, at the U.S. Department of Labor as the deputy secretary of labor, at the U.S. Supreme Court as a law clerk for Justice Antonin Scalia, and at the U.S. Court of Appeals for the D.C. Circuit as a law clerk for Judge Stephen F. Williams. He earned his B.A. from Northwestern University, his Master of Arts (Oxon.) from Oxford University, and his Juris Doctor from Harvard Law School. On July 16, 2025, the Board appointed John W. Rogers, Jr. as Lead Director and Henry S. Bienen as Chairperson of the Compensation and Governance Committee.공시 • Jul 15Ryan Specialty Holdings, Inc. to Report Q2, 2025 Results on Jul 31, 2025Ryan Specialty Holdings, Inc. announced that they will report Q2, 2025 results After-Market on Jul 31, 2025공시 • Jul 02Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of JM Wilson Corporation.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire JM Wilson Corporation on June 5, 2025. JM Wilson is based in Michigan and its operations will become a part of RT Binding Authority, the binding authority specialty of Ryan Specialty.JM Wilson generated approximately $19 million of operating revenue for the 12 months ended January 31, 2025. The transaction is expected to close in the third quarter of 2025. Philo Smith & Co. acted as financial advisor for JM Wilson Corporation. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of JM Wilson Corporation on July 1, 2025.Recent Insider Transactions • May 20President recently sold US$3.5m worth of stockOn the 16th of May, Jeremiah Bickham sold around 50k shares on-market at roughly US$70.09 per share. This transaction amounted to 96% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Jeremiah's only on-market trade for the last 12 months.Major Estimate Revision • May 09Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$1.12 to US$0.858 per share. Revenue forecast steady at US$3.08b. Net income forecast to grow 524% next year vs 12% growth forecast for Insurance industry in the US. Consensus price target of US$75.90 unchanged from last update. Share price rose 8.2% to US$70.13 over the past week.Declared Dividend • May 05First quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 13th May 2025 Payment date: 27th May 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 108%. Cash payout ratio: 29%.New Risk • May 02New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.9% Last year net profit margin: 3.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin).Reported Earnings • May 02First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2025 results: US$0.22 loss per share (down from US$0.14 profit in 1Q 2024). Revenue: US$690.2m (up 28% from 1Q 2024). Net loss: US$4.39m (down 127% from profit in 1Q 2024). Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.공시 • May 02+ 1 more updateRyan Specialty Holdings, Inc. Declares Regular Quarterly Dividend, Payable on May 27, 2025On May 1, 2025, the board of directors of Ryan Specialty Holdings, Inc. declared a regular quarterly dividend of $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on May 27, 2025 to stockholders of record as of the close of business on May 13, 2025. A portion of the dividend, $0.05 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company's Class A common stock and the holders of the LLC Common Units.공시 • Apr 07Ryan Specialty Holdings, Inc., Annual General Meeting, May 30, 2025Ryan Specialty Holdings, Inc., Annual General Meeting, May 30, 2025.공시 • Apr 04Ryan Specialty Holdings, Inc. to Report Q1, 2025 Results on May 01, 2025Ryan Specialty Holdings, Inc. announced that they will report Q1, 2025 results After-Market on May 01, 2025공시 • Mar 28Ryan Specialty Holdings, Inc. Appoints Stephen P. Keogh as Chief Operating Officer, Effective May 1, 2025On March 27, 2025, Ryan Specialty Holdings, Inc. announced the appointment of Mr. Stephen P. Keogh to the position of Chief Operating Officer of the Company, effective May 1, 2025. Stephen P. Keogh, age 58, was most recently Senior Advisor to the Office of President, Aon plc, a position he held from October 2021 until his retirement in September 2022. Prior to that, commencing June 2019, Mr. Keogh was President of Aon plc's Commercial Risk Solutions, the global risk management business of Aon. Mr. Keogh brings in excess of thirty- two years of experience at Aon, where he held positions in operations, finance and accounting, technology, human resources and executive management. Mr. Keogh is a member of the Board of Trustees of the Illinois Institute of Chicago and earned a Bachelor’s degree from the University of Illinois.Recent Insider Transactions Derivative • Mar 18Executive VP & Chief Revenue Officer exercised options and sold US$2.1m worth of stockOn the 14th of March, Brendan Mulshine exercised options to acquire 30k shares at no cost and sold these for an average price of US$69.30 per share. This trade did not impact their existing holding. Since June 2024, Brendan's direct individual holding has decreased from 76.50k shares to 75.82k. Company insiders have collectively sold US$179m more than they bought, via options and on-market transactions in the last 12 months.Major Estimate Revision • Feb 28Consensus EPS estimates fall by 12%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from US$3.02b to US$3.05b. EPS estimate fell from US$1.44 to US$1.27 per share. Net income forecast to grow 212% next year vs 9.4% growth forecast for Insurance industry in the US. Consensus price target broadly unchanged at US$75.60. Share price rose 2.1% to US$70.03 over the past week.Declared Dividend • Feb 25Fourth quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 4th March 2025 Payment date: 18th March 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 56%. Cash payout ratio: 27%.New Risk • Feb 24New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 33% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Significant insider selling over the past 3 months (US$34m sold).공시 • Feb 21+ 1 more updateRyan Specialty Holdings, Inc. Declares Regular Quarterly Dividend on Outstanding Class A Common Stock, Payable on March 18, 2025On February 20, 2025, Ryan Specialty Holdings, Inc. declared and increased the Company's regular quarterly dividend by 9.1% to $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on March 18, 2025 to stockholders of record as of the close of business on March 4, 2025. A portion of the dividend, $0.05 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company's Class A common stock and the holders of the LLC Common Units.공시 • Feb 04Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others for approximately $530 million on January 7, 2025. The upfront cash consideration is exclusive of VSIC and any earnout consideration. Velocity generated approximately $81 million of operating revenue for the 12 months ended December 31, 2024. The acquisition of Velocity is expected to close in early 2025. Andrew Jamieson of Debevoise & Plimpton LLP acted as legal advisor to Oaktree and Velocity Risk. Howden Tiger Capital Markets & Advisory, LLC acted as financial advisor to Oaktree and Velocity Risk. Insurance Advisory Partners LLC acted as financial advisor to Oaktree and Velocity Risk. Sidley Austin LLP acted as legal advisor to Ryan Specialty. J.P. Morgan Securities LLC acted as financial advisor to Ryan Specialty. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others on February 3, 2025.Recent Insider Transactions • Jan 16Director recently sold US$6.5m worth of stockOn the 15th of January, Nicholas Cortezi sold around 99k shares on-market at roughly US$65.50 per share. This transaction amounted to 28% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth US$7.0m. Insiders have been net sellers, collectively disposing of US$25m more than they bought in the last 12 months.공시 • Jan 10Ryan Specialty Holdings, Inc. to Report Q4, 2024 Results on Feb 20, 2025Ryan Specialty Holdings, Inc. announced that they will report Q4, 2024 results After-Market on Feb 20, 2025공시 • Jan 09Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire Velocity Risk Underwriters, LLC from Velocity Holdco, LLC for approximately $530 million.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others for approximately $530 million on January 7, 2025. The upfront cash consideration is exclusive of VSIC and any earnout consideration. Velocity generated approximately $81 million of operating revenue for the 12 months ended December 31, 2024. The acquisition of Velocity is expected to close in early 2025. Andrew Jamieson of Debevoise & Plimpton LLP acted as legal advisor to Oaktree and Velocity Risk. Howden Tiger Capital Markets & Advisory, LLC acted as financial advisor to Oaktree and Velocity Risk. Insurance Advisory Partners LLC acted as financial advisor to Oaktree and Velocity Risk. Sidley Austin LLP acted as legal advisor to Ryan Specialty. J.P. Morgan Securities LLC acted as financial advisor to Ryan Specialty.Recent Insider Transactions • Dec 18Director recently sold US$7.0m worth of stockOn the 17th of December, Nicholas Cortezi sold around 105k shares on-market at roughly US$66.54 per share. This transaction amounted to 21% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$18m more than they bought in the last 12 months.Recent Insider Transactions Derivative • Nov 14Executive VP exercised options and sold US$1.1m worth of stockOn the 8th of November, Mark Katz exercised options to acquire 15k shares at no cost and sold these for an average price of US$71.39 per share. This trade did not impact their existing holding. Since March 2024, Mark's direct individual holding has increased from 13.26k shares to 14.14k. Company insiders have collectively sold US$144m more than they bought, via options and on-market transactions in the last 12 months.공시 • Nov 05Ryan Specialty Holdings, Inc. acquired Innovisk Capital Partners LLP from BHMS Investments, LP and ABRY Partners, LLC.Ryan Specialty Holdings, Inc. announced the acquisition of Innovisk Capital Partners LLP from BHMS Investments, LP and ABRY Partners, LLC on October 30, 2024. The acquisition is expected to close early next month. Ardea Partners International Llp acted as financial advisor to Innovisk Capital Partners LLP. Kirkland & Ellis LLP and Hill Dickinson LLP acted as legal advisor to Innovisk Capital Partners LLP, BHMS Investments, LP and ABRY Partners, LLC. Ryan Specialty Holdings, Inc. completed the acquisition of Innovisk Capital Partners LLP from BHMS Investments, LP and ABRY Partners, LLC on November 4, 2024.공시 • Nov 02+ 1 more updateRyan Specialty Holdings, Inc. Maintains Earnings Guidance for the Full Year 2024Ryan Specialty Holdings, Inc. maintained earnings guidance for the full year 2024. The Company is maintaining its full year 2024 outlook for Organic Revenue Growth Rate is between 13.0% – 14.0%.Reported Earnings • Nov 01Third quarter 2024 earnings: EPS misses analyst expectationsThird quarter 2024 results: EPS: US$0.15 (up from US$0.044 loss in 3Q 2023). Revenue: US$588.1m (up 21% from 3Q 2023). Net income: US$28.6m (up US$33.8m from 3Q 2023). Profit margin: 4.9% (up from net loss in 3Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 24%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.공시 • Oct 03+ 1 more updateRyan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Assets of Geo Underwriting Services Limited.Ryan Specialty Holdings, Inc. (NYSE:RYAN) agreed to acquire Assets of Geo Underwriting Services Limited on September 3, 2024. The transaction is expected to close during the third quarter of this year. Walter Craft will be appointed as Managing Director of Ryan Financial Lines and Benelux and DACH and will join the Ryan Financial Lines Executive Committee. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Assets of Geo Underwriting Services Limited on October 1, 2024.공시 • Sep 17Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Property and Casualty MGUs of Ethos Specialty Insurance, LLC from Ethos Specialty Insurance Services LLC.Ryan Specialty Holdings, Inc. (NYSE:RYAN) agreed to acquire Property and Casualty MGUs of Ethos Specialty Insurance, LLC from Ethos Specialty Insurance Services LLC on September 3, 2024. Ethos P&C generated approximately $11 million of operating revenue for the 12 months ended June 30, 2024. The acquisition is expected to close during September 2024. Evercore served as exclusive financial advisor to Ascot. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Property and Casualty MGUs of Ethos Specialty Insurance, LLC from Ethos Specialty Insurance Services LLC on September 16, 2024.Recent Insider Transactions • Sep 02Director recently sold US$1.5m worth of stockOn the 29th of August, Nicholas Cortezi sold around 24k shares on-market at roughly US$64.59 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth US$6.8m. Insiders have been net sellers, collectively disposing of US$10m more than they bought in the last 12 months.Recent Insider Transactions • Aug 21Director recently sold US$1.1m worth of stockOn the 19th of August, Nicholas Cortezi sold around 17k shares on-market at roughly US$64.69 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$1.6m more than they bought in the last 12 months.새로운 내러티브 • Aug 21Expanding Broker Networks And Tech Innovation Fuel Revenue And Margin Growth Acquiring U.S. Assure enhances Ryan Specialty's broker network and market reach, aligning with growth sectors like construction, promising revenue increases. Recent Insider Transactions Derivative • Aug 12President & Director exercised options and sold US$125m worth of stockOn the 9th of August, Timothy Turner exercised options to acquire 2m shares at no cost and sold these for an average price of US$62.45 per share. This trade did not impact their existing holding. Since March 2024, Timothy's direct individual holding has increased from 11.04k shares to 15.07k. Company insiders have collectively sold US$132m more than they bought, via options and on-market transactions in the last 12 months.이익 및 매출 성장 예측NYSE:RYAN - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20283,852434745529712/31/20273,5313806324101612/31/20263,262254466326163/31/20263,101109552619N/A12/31/20252,99563573644N/A9/30/20252,90671569640N/A6/30/20252,75558510571N/A3/31/20252,59451432489N/A12/31/20242,45695468515N/A9/30/20242,325102439482N/A6/30/20242,22478440487N/A3/31/20242,11764485520N/A12/31/20232,02761447477N/A9/30/20231,93557408435N/A6/30/20231,85574294316N/A3/31/20231,77368218242N/A12/31/20221,71262313336N/A9/30/20221,663-19255270N/A6/30/20221,608-32-25330N/A3/31/20221,5086-70283N/A12/31/20211,432-7-79273N/A9/30/20211,38151-64288N/A6/30/20211,26563166175N/A3/31/20211,121508393N/A12/31/20201,01768118135N/A12/31/201975864N/A150N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: RYAN 의 연간 예상 수익 증가율(46.9%)이 saving rate(3.5%)보다 높습니다.수익 vs 시장: RYAN 의 연간 수익(46.9%)이 US 시장(16.8%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: RYAN 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: RYAN 의 수익(연간 7.8%)이 US 시장(연간 11.6%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: RYAN 의 수익(연간 7.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: RYAN의 자본 수익률은 3년 후 88.6%로 매우 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YInsurance 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 01:00종가2026/05/21 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Ryan Specialty Holdings, Inc.는 26명의 분석가가 다루고 있습니다. 이 중 16명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Tracy Dolin-BenguiguiBarclaysTaylor ScottBarclaysTracy Dolin-BenguiguiBarclays23명의 분석가 더 보기
Major Estimate Revision • May 11Consensus EPS estimates fall by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.36b to US$3.26b. EPS estimate also fell from US$1.00 per share to US$0.831 per share. Net income forecast to grow 162% next year vs 3.0% growth forecast for Insurance industry in the US. Consensus price target down from US$48.59 to US$42.88. Share price rose 5.6% to US$31.31 over the past week.
Price Target Changed • Apr 10Price target decreased by 7.3% to US$49.65Down from US$53.53, the current price target is an average from 17 analysts. New target price is 44% above last closing price of US$34.57. Stock is down 53% over the past year. The company is forecast to post earnings per share of US$1.00 for next year compared to US$0.50 last year.
Major Estimate Revision • Apr 09Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.44b to US$3.39b. EPS estimate also fell from US$1.12 per share to US$1.01 per share. Net income forecast to grow 387% next year vs 3.7% growth forecast for Insurance industry in the US. Consensus price target down from US$53.53 to US$50.35. Share price rose 4.1% to US$34.89 over the past week.
Major Estimate Revision • Feb 20Consensus EPS estimates increase by 11%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from US$3.58b to US$3.46b. EPS estimate rose from US$1.02 to US$1.12. Net income forecast to grow 428% next year vs 9.7% growth forecast for Insurance industry in the US. Consensus price target down from US$64.31 to US$57.25. Share price fell 6.9% to US$41.33 over the past week.
Price Target Changed • Feb 13Price target decreased by 10.0% to US$58.25Down from US$64.69, the current price target is an average from 16 analysts. New target price is 50% above last closing price of US$38.71. Stock is down 44% over the past year. The company is forecast to post earnings per share of US$0.83 for next year compared to US$0.50 last year.
Major Estimate Revision • Nov 06Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.69 to US$0.766. Revenue forecast steady at US$3.08b. Net income forecast to grow 319% next year vs 9.9% growth forecast for Insurance industry in the US. Consensus price target down from US$72.00 to US$68.31. Share price rose 12% to US$56.94 over the past week.
속보 • 5hRyan Specialty Holdings Investigated for Securities Fraud After Revenue Slowdown and Stock DropPomerantz LLP has opened an investigation into Ryan Specialty Holdings and certain executives over potential securities fraud and unlawful business practices following its 2025 results. The probe is tied to disclosures of slower fourth-quarter organic revenue growth, lower profit margins versus the prior year, a cautious 2026 outlook, and a stock drop of nearly 13%. Cooper Investors highlighted Ryan Specialty as a key detractor in its first-quarter 2026 fund commentary, citing a weakening insurance pricing environment and a rapidly shifting insurance cycle, especially in property insurance. Taken together, the legal scrutiny and tougher insurance pricing backdrop point to higher near-term uncertainty around earnings quality, growth durability, and management’s communication with the market. Investors may want to track the progress of the Pomerantz investigation and how management addresses the changing insurance cycle, particularly its continued investment in talent and technology during a softer pricing phase.
Major Estimate Revision • May 11Consensus EPS estimates fall by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.36b to US$3.26b. EPS estimate also fell from US$1.00 per share to US$0.831 per share. Net income forecast to grow 162% next year vs 3.0% growth forecast for Insurance industry in the US. Consensus price target down from US$48.59 to US$42.88. Share price rose 5.6% to US$31.31 over the past week.
Declared Dividend • May 04First quarter dividend of US$0.13 announcedShareholders will receive a dividend of US$0.13. Ex-date: 12th May 2026 Payment date: 26th May 2026 Dividend yield will be 1.6%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (25% cash payout ratio). The dividend has increased by an average of 8.7% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 185% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • May 02Ryan Specialty Holdings, Inc. announces Quarterly dividend, payable on May 26, 2026Ryan Specialty Holdings, Inc. announced Quarterly dividend of USD 0.1300 per share payable on May 26, 2026, ex-date on May 12, 2026 and record date on May 12, 2026.
Reported Earnings • May 01First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2026 results: EPS: US$0.14 (up from US$0.22 loss in 1Q 2025). Revenue: US$795.2m (up 18% from 1Q 2025). Net income: US$40.6m (up US$68.2m from 1Q 2025). Profit margin: 5.1% (up from net loss in 1Q 2025). Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 14%. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 10% per year.
내러티브 업데이트 • Apr 29RYAN: AI Productivity And M&A Pipeline Are Expected To Sustain EarningsAnalysts have reduced the fair value estimate for Ryan Specialty Holdings from about $80.34 to $69.03. This reflects updated assumptions for slower revenue growth, slightly softer margins, and a modestly higher discount rate following a series of price target cuts across the Street.
내러티브 업데이트 • Apr 14RYAN: AI Risk Repricing Will Meet Capital Returns And M&A ExecutionRyan Specialty Holdings' analyst price target has been revised lower to $36 from $43, as analysts incorporate more cautious assumptions on revenue growth, profit margins, and future P/E multiples following a broad series of recent target cuts across the broker group. Analyst Commentary Recent research points to a clear shift toward more cautious assumptions on Ryan Specialty Holdings, with several firms trimming price targets and at least one downgrade reflecting concern around growth durability, margins, and valuation support.
Price Target Changed • Apr 10Price target decreased by 7.3% to US$49.65Down from US$53.53, the current price target is an average from 17 analysts. New target price is 44% above last closing price of US$34.57. Stock is down 53% over the past year. The company is forecast to post earnings per share of US$1.00 for next year compared to US$0.50 last year.
Major Estimate Revision • Apr 09Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$3.44b to US$3.39b. EPS estimate also fell from US$1.12 per share to US$1.01 per share. Net income forecast to grow 387% next year vs 3.7% growth forecast for Insurance industry in the US. Consensus price target down from US$53.53 to US$50.35. Share price rose 4.1% to US$34.89 over the past week.
공시 • Apr 07Ryan Specialty Holdings, Inc. to Report Q1, 2026 Results on Apr 30, 2026Ryan Specialty Holdings, Inc. announced that they will report Q1, 2026 results After-Market on Apr 30, 2026
내러티브 업데이트 • Mar 31RYAN: AI Productivity And Capital Returns Will Support Future RepricingAnalysts have lowered price targets on Ryan Specialty Holdings by roughly $5 to $15 to reflect concerns about slower excess and surplus market growth and fears of AI-related disruption, even as some point to potential support from AI-driven productivity and margins that appear more resilient than recent trading suggests. Analyst Commentary Recent Street research on Ryan Specialty reflects a clear tilt toward more cautious views, with several firms cutting price targets and, in at least one case, lowering the stock rating.
내러티브 업데이트 • Mar 17RYAN: Core Brokerage Role Will Benefit From AI Productivity TailwindThe updated analyst price target for Ryan Specialty Holdings edges up to $55.25 from $54.88, as analysts weigh softer revenue growth assumptions against slightly higher margin expectations and a modestly lower future P/E. They are also factoring in recent sector wide target cuts tied to AI disruption concerns and excess and surplus market deceleration.
내러티브 업데이트 • Mar 03RYAN: Core Brokerage Role Will Withstand Softer P And C CycleAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings from about $66.53 to $54.88, reflecting lower Street price targets in the $43 to $65 range and updated expectations for slower revenue growth, softer profit margins, and a higher future P/E multiple. Analyst Commentary Recent Street research around Ryan Specialty Holdings has turned more cautious overall, with several firms cutting price targets and, in one case, lowering the rating.
New Risk • Feb 25New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Payout ratio: 96% Dividend yield: 1.4% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Dividend is not well covered by earnings (96% payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).
Recent Insider Transactions • Feb 25Director recently bought US$1.0m worth of stockOn the 23rd of February, Patrick Ryan bought around 26k shares on-market at roughly US$39.98 per share. This transaction amounted to 3.9% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold US$2.8m more in shares than they bought in the last 12 months.
Major Estimate Revision • Feb 20Consensus EPS estimates increase by 11%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from US$3.58b to US$3.46b. EPS estimate rose from US$1.02 to US$1.12. Net income forecast to grow 428% next year vs 9.7% growth forecast for Insurance industry in the US. Consensus price target down from US$64.31 to US$57.25. Share price fell 6.9% to US$41.33 over the past week.
내러티브 업데이트 • Feb 17RYAN: Softening P&C Cycle And Capital Moves Will Shape Future RepricingAnalysts have trimmed the fair value estimate for Ryan Specialty Holdings to $43 from $52, reflecting updated views on slower revenue growth assumptions, slightly lower profit margins, and a reduced future P/E multiple across recent Street research. Analyst Commentary Recent Street research on Ryan Specialty Holdings has shifted in a more cautious direction, with several bearish analysts trimming price targets and highlighting potential pressure on growth, margins, and valuation multiples.
New Risk • Feb 16New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 3.9% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).
Declared Dividend • Feb 16Fourth quarter dividend increased to US$0.13Dividend of US$0.13 is 8.3% higher than last year. Ex-date: 24th February 2026 Payment date: 10th March 2026 Dividend yield will be 1.3%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is not adequately covered by earnings (96% earnings payout ratio). However, it is well covered by cash flows (24% cash payout ratio). The dividend has increased by an average of 8.7% per year over the past 2 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 7.1% to bring the payout ratio under control. EPS is expected to grow by 173% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
New Risk • Feb 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Large one-off items impacting financial results.
Price Target Changed • Feb 13Price target decreased by 10.0% to US$58.25Down from US$64.69, the current price target is an average from 16 analysts. New target price is 50% above last closing price of US$38.71. Stock is down 44% over the past year. The company is forecast to post earnings per share of US$0.83 for next year compared to US$0.50 last year.
공시 • Feb 13+ 2 more updatesRyan Specialty Holdings, Inc., Annual General Meeting, Apr 28, 2026Ryan Specialty Holdings, Inc., Annual General Meeting, Apr 28, 2026.
공시 • Feb 05Ryan Specialty Appoints Stephen Stewart as CEO of Ryan Specialty Canada LimitedRyan Specialty announced the appointment of Stephen Stewart, President & CEO of Stewart Specialty Risk Underwriting, a Ryan Specialty managing general underwriter, to the additional role Chief Executive Officer of Ryan Specialty Canada Limited, the newly formed Canadian operating and holding entity for Ryan Specialty’s underwriting management businesses in Canada. Ryan Specialty Canada Limited is headquartered in Toronto. In Stephen Stewart’s additional role as CEO of Ryan Specialty Canada Limited, he will lead the continued growth of Ryan Specialty’s Canadian platform while maintaining the underwriting discipline and specialist focus that have defined Stewart Specialty Risk Underwriting and Ryan Specialty’s other Canadian units. The legal integration is already underway, and teams are actively engaging with new colleagues across underwriting, operations, and support functions to build a unified Canadian platform.
내러티브 업데이트 • Feb 03RYAN: Double Digit Organic Expansion Is Expected To Sustain Earnings Through Softer P&C CycleAnalysts now estimate Ryan Specialty Holdings' fair value at about $80.34, up from $76.00. This change reflects updated assumptions for slower revenue growth, lower profit margins, and a higher future P/E multiple across recent P&C insurance sector research.
내러티브 업데이트 • Jan 19RYAN: Softening P&C Cycle And Governance Shift Will Shape Future Share RepricingAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings to $52 from $58, reflecting a lower future P/E assumption, while updated models still factor in steady revenue growth and margins across a softening property and casualty cycle. Analyst Commentary Recent Street research on Ryan Specialty presents a mixed picture, with several firms trimming price targets even as some maintain positive ratings.
공시 • Jan 13Ryan Specialty Holdings, Inc. to Report Q4, 2025 Results on Feb 12, 2026Ryan Specialty Holdings, Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 12, 2026
내러티브 업데이트 • Jan 05RYAN: Double Digit Organic Expansion Outlook Will Drive Future Share RepricingAnalysts have trimmed their fair value estimate for Ryan Specialty Holdings to $58 from $60, reflecting updated views on revenue growth potential, profit margins, and a lower future P/E multiple after a mix of recent target cuts and raises across the Street. Analyst Commentary Recent Street research on Ryan Specialty Holdings shows a mix of optimism on the business model and caution on how much investors should be willing to pay for the stock.
내러티브 업데이트 • Dec 18RYAN: Double Digit Organic Expansion Is Expected To Drive Strong Earnings AheadAnalysts have trimmed their price target for Ryan Specialty Holdings to $76 from $90, reflecting a modestly higher discount rate and more measured revenue growth expectations, even as they highlight resilient profit margins, double digit organic growth prospects into 2025 and 2026, and a still supportive earnings backdrop for property and casualty insurers. Analyst Commentary Bullish analysts acknowledge a reset in valuation assumptions but continue to frame Ryan Specialty as a long term compounder, citing durable organic growth, expanding distribution, and a supportive earnings environment for specialty focused intermediaries.
Recent Insider Transactions Derivative • Dec 16CEO & Director exercised options and sold US$6.9m worth of stockOn the 12th of December, Timothy Turner exercised options to acquire 130k shares at no cost and sold these for an average price of US$53.61 per share. This trade did not impact their existing holding. For the year to December 2020, Timothy's total compensation was 20% salary and 80% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Timothy's direct individual holding has increased from 8.10k shares to 12.55k. Company insiders have collectively sold US$46m more than they bought, via options and on-market transactions in the last 12 months.
공시 • Dec 09+ 1 more updateRyan Specialty Holdings, Inc. Announces Retirement of Bobby Le Blanc from Board of Directors, Effective February 11, 2026Ryan Specialty Holdings, Inc. announced that by mutual agreement following Onex Corporation’s sale of its remaining shares of Ryan Specialty, Bobby Le Blanc will retire from his service on the Ryan Specialty Board of Directors effective February 11, 2026. Mr. Le Blanc, Onex’ CEO, has served on Ryan Specialty’s Board since 2018, originally as Onex’ nominee with its investment in Ryan Specialty. Bobby Le Blanc contributed significantly to Ryan Specialty's growth and market leadership in specialty insurance solutions during his tenure on the board.
내러티브 업데이트 • Dec 04RYAN: Double Digit Organic Expansion Will Outlast Softening Property And Casualty CycleAnalysts have trimmed their average price target on Ryan Specialty Holdings by about $2 to roughly $66.50. This reflects slightly lower assumptions for growth and margins amid softening property and casualty pricing, even as they continue to highlight the company's double digit organic revenue prospects and generally favorable long term earnings outlook.
내러티브 업데이트 • Nov 20RYAN: Earnings Strength Will Overcome Sector Headwinds Into 2025Ryan Specialty Holdings' analyst price target saw a modest increase to $68.46, reflecting analyst expectations for slightly improved revenue growth and profit margins in light of resilient earnings and favorable industry conditions. Analyst Commentary Recent analyst coverage of Ryan Specialty Holdings reflects a nuanced perspective, with sentiment split between optimism about the firm's growth prospects and caution stemming from broader sector challenges.
New Risk • Nov 07New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.1% Last year net profit margin: 4.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.1% net profit margin).
Major Estimate Revision • Nov 06Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.69 to US$0.766. Revenue forecast steady at US$3.08b. Net income forecast to grow 319% next year vs 9.9% growth forecast for Insurance industry in the US. Consensus price target down from US$72.00 to US$68.31. Share price rose 12% to US$56.94 over the past week.
내러티브 업데이트 • Nov 05RYAN: Ongoing Earnings Resilience And Sector Demand Will Drive Upside MomentumThe average analyst price target for Ryan Specialty Holdings has been revised downward by approximately $3.69 to $68.31. This reflects more cautious near-term assumptions on margin and sector growth trends, despite ongoing buy ratings and optimism around resilient earnings and organic growth.
분석 기사 • Nov 03Ryan Specialty Holdings (NYSE:RYAN) Is Paying Out A Dividend Of $0.12The board of Ryan Specialty Holdings, Inc. ( NYSE:RYAN ) has announced that it will pay a dividend on the 25th of...
Declared Dividend • Nov 03Third quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 10th November 2025 Payment date: 25th November 2025 Dividend yield will be 0.9%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (16% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 4.4% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 148% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Oct 31Third quarter 2025 earnings: EPS in line with analyst expectations despite revenue beatThird quarter 2025 results: EPS: US$0.49 (up from US$0.15 in 3Q 2024). Revenue: US$754.6m (up 28% from 3Q 2024). Net income: US$62.6m (up 249% from 3Q 2024). Profit margin: 8.3% (up from 3.1% in 3Q 2024). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
공시 • Oct 31+ 1 more updateRyan Specialty Holdings, Inc. Declares A Regular Quarterly Dividend, Payable on November 25, 2025On October 30, 2025, Ryan Specialty Holdings, Inc.’s board of directors declared a regular quarterly dividend of $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on November 25, 2025, to stockholders of record as of the close of business on November 11, 2025.
내러티브 업데이트 • Oct 22Analysts Weigh Resilient Margins and Growth Outlook for Ryan Specialty Holdings Amid Valuation ShiftsAnalysts have slightly lowered their average price target for Ryan Specialty Holdings, noting resilient profit margins and earnings support from lighter catastrophe losses even as the sector faces growth headwinds. Analyst Commentary Recent Street research on Ryan Specialty Holdings highlights a mix of optimism and caution, reflecting varying outlooks for the company as growth moderates in the broader insurance sector.
Major Estimate Revision • Oct 09Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$0.622 to US$0.693. Revenue forecast steady at US$3.07b. Net income forecast to grow 543% next year vs 13% growth forecast for Insurance industry in the US. Consensus price target broadly unchanged at US$71.85. Share price was steady at US$55.63 over the past week.
공시 • Oct 09Ryan Specialty Holdings, Inc. Announces Executive ChangesOn October 8, 2025, the Board of Directors of Ryan Specialty Holdings, Inc. (the Company" or Ryan Specialty") appointed Stephen P. Keogh as Co-President and Chief Operating Officer and Brendan M. Mulshine as Co-President and Chief Revenue Officer of the Company to succeed Jeremiah Bickham as President, effective October 9, 2025. Stephen P. Keogh, age 59, has served as the Company's Chief Operating Officer since May 2025. Previously, Mr. Keogh was the Senior Advisor to the Office of President, Aon plc, a position he held from October 2021 until his retirement in September 2022. Prior to that, commencing June 2019, Mr. Keogh was President of Aon plc's Commercial Risk Solutions, the global risk management business of Aon. Mr. Keogh holds in excess of thirty-two years of experience at Aon, where he held positions in operations, finance and accounting, technology, human resources and executive management. Mr. Keogh earned a Bachelor's degree from the University of Illinois. Brendan M. Mulshine, age 59, has served as the Company's Executive Vice President and Chief Revenue Officer since 2020 and previously served as the Company's Executive Vice President and Managing Director from 2012 through 2020. From 1995 to 2012, Mr. Mulshine held various leadership positions at Aon Re, working with domestic and global insurance company clients on their reinsurance capital needs. Mr. Mulshine began his career practicing law in New York City. He earned a Bachelor of Arts from Yale College, a Juris Doctor from the University of Notre Dame School of Law, and a Master of Business Administration from Northwestern University's Kellogg School of Management. Changes to Messrs. On October 2, 2025, the Company and Mr. Jeremiah Bickham agreed that, effective October 8, 2025, Mr. Bickham would be transitioning from his role as President to serve as a non-employee strategic advisor to the Company through January 1, 2026.
내러티브 업데이트 • Oct 08Emerging Risks And Data Analytics Will Expand Future OpportunitiesAnalysts have modestly reduced their price target for Ryan Specialty Holdings, citing commercial property growth headwinds and a slight decrease in projected revenue growth. The fair value estimate is now lowered by approximately $1.42 to $72.00 per share.
공시 • Oct 03Ryan Specialty Holdings, Inc. to Report Q3, 2025 Results on Oct 30, 2025Ryan Specialty Holdings, Inc. announced that they will report Q3, 2025 results After-Market on Oct 30, 2025
공시 • Sep 10Ryan Specialty Holdings, Inc. Appoints Michael G. Bungert to Its Board of Directors and Serves as A Member of Its Compensation and Governance Committee, Effective September 3, 2025Ryan Specialty Holdings, Inc. on September 3, 2025 elected Michael G. Bungert as a director and assigned him to its Compensation and Governance Committee, effective September 9, 2025. Mr. Bungert's initial term as a director will expire at the 2026 annual meeting of the Company's stockholders, at which time his continued Board service will be subject to renomination and stockholder approval. There are no transactions in which Mr. Bungert has or will have an interest that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K under the Exchange Act, at this time. The selection of Mr. Bungert was not pursuant to any arrangement or understanding between him and any other person. Mr. Bungert will participate in the Company's standard non-employee director compensation arrangements. Mr. Bungert will receive a grant of restricted stock units (RSUs) with a grant date fair value equal to $200,000 (prorated for the portion of the year for which he served as a director) that fully vest on the grant date and each RSU represents a right to receive one fully vested share of the Company's Class A common stock. The Company will make the annual equity grant of RSUs on the date of the Company's next annual meeting of stockholders and such grant will be compensation for the prior year of service, or portion thereof. Additionally, Mr. Bungert will be entitled to receive a cash payment in the amount of $120,000 per year, paid quarterly, in respect of his service as a member of the Board, with no additional cash compensation paid on account of his service on the Compensation and Governance Committee. Mr. Bungert has had a long and illustrious reinsurance career, most recently as Chairman of Aon Re Global from which he retired in 2024 after 11 years in that position. Prior to being Chairman, Mr. Bungert was CEO of Aon Re, a position he assumed in 1998. Mr. Bungert started his career in reinsurance in 1977 as an underwriter trainee at Continental Casualty Company. He then joined CNA Re in 1979 as a London-based North American underwriter. In 1984, Mr. Bungert joined reinsurance intermediary Thomas A. Greene Inc. Intermediaries in Chicago and subsequently joined Aon Re in 1989.
내러티브 업데이트 • Sep 04Emerging Risks And Data Analytics Will Expand Future OpportunitiesAmid increased competition in personal auto, softened reinsurance pricing, and pressure on underwriting margins for carriers, analysts have adopted a more cautious outlook for the sector—though brokers like Ryan Specialty are expected to demonstrate relative earnings resilience—with the consensus price target remaining unchanged at $73.42. Analyst Commentary Increased competition in the personal auto insurance market and softened reinsurance pricing, resulting in a more cautious outlook and modest reductions of price targets.
Major Estimate Revision • Aug 07Consensus EPS estimates fall by 14%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$0.853 to US$0.733 per share. Revenue forecast steady at US$3.08b. Net income forecast to grow 571% next year vs 11% growth forecast for Insurance industry in the US. Consensus price target down from US$78.00 to US$75.60. Share price fell 2.7% to US$59.55 over the past week.
분석 기사 • Aug 04Ryan Specialty Holdings (NYSE:RYAN) Will Pay A Dividend Of $0.12Ryan Specialty Holdings, Inc. ( NYSE:RYAN ) has announced that it will pay a dividend of $0.12 per share on the 26th of...
Declared Dividend • Aug 04Second quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 12th August 2025 Payment date: 26th August 2025 Dividend yield will be 0.8%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is not covered by earnings (233% earnings payout ratio). However, it is well covered by cash flows (25% cash payout ratio). The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years. The company's earnings per share (EPS) would need to grow by 159% to bring the payout ratio under control. EPS is expected to grow by 418% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
Reported Earnings • Aug 01Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2025 results: EPS: US$0.41 (up from US$0.38 in 2Q 2024). Revenue: US$855.2m (up 26% from 2Q 2024). Net income: US$124.7m (up 176% from 2Q 2024). Profit margin: 15% (up from 6.6% in 2Q 2024). Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) missed analyst estimates by 1.9%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
공시 • Aug 01+ 1 more updateRyan Specialty Holdings, Inc. Updates Earnings Guidance for the Full Year 2025Ryan Specialty Holdings, Inc. updated earnings guidance for the full year 2025. Organic Revenue Growth Rate guidance for full year 2025 is between 9.0% – 11.0%, compared to the company’s prior guidance of 11% – 13.0%.
공시 • Jul 18Ryan Specialty Holdings, Inc. Announces Board and Committee ChangesRyan Specialty Holdings, Inc. shared the sad news of the loss of Director, D. Cameron (“Cam”) Findlay, who unexpectedly passed away earlier this month. Mr. Findlay served on the Ryan Specialty Board, including its pre-IPO predecessor, since 2012, and was most recently the chairperson of the Compensation and Governance Committee, a member of the Executive Committee, and the Board’s Lead Director. From 2013 until his retirement in 2023, Mr. Findlay was the Senior Vice President, General Counsel, and Secretary of Archer Daniels Midland Company. From 2009 to 2013, he was Senior Vice President and General Counsel of Medtronic, Inc., and from 2003 to 2009 he served as Executive Vice President and General Counsel of Aon Corporation. In addition to his time as a lawyer and businessperson, Mr. Findlay had a distinguished career in government service, including at the White House as deputy assistant to President George H.W. Bush, at the U.S. Department of Labor as the deputy secretary of labor, at the U.S. Supreme Court as a law clerk for Justice Antonin Scalia, and at the U.S. Court of Appeals for the D.C. Circuit as a law clerk for Judge Stephen F. Williams. He earned his B.A. from Northwestern University, his Master of Arts (Oxon.) from Oxford University, and his Juris Doctor from Harvard Law School. On July 16, 2025, the Board appointed John W. Rogers, Jr. as Lead Director and Henry S. Bienen as Chairperson of the Compensation and Governance Committee.
공시 • Jul 15Ryan Specialty Holdings, Inc. to Report Q2, 2025 Results on Jul 31, 2025Ryan Specialty Holdings, Inc. announced that they will report Q2, 2025 results After-Market on Jul 31, 2025
공시 • Jul 02Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of JM Wilson Corporation.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire JM Wilson Corporation on June 5, 2025. JM Wilson is based in Michigan and its operations will become a part of RT Binding Authority, the binding authority specialty of Ryan Specialty.JM Wilson generated approximately $19 million of operating revenue for the 12 months ended January 31, 2025. The transaction is expected to close in the third quarter of 2025. Philo Smith & Co. acted as financial advisor for JM Wilson Corporation. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of JM Wilson Corporation on July 1, 2025.
Recent Insider Transactions • May 20President recently sold US$3.5m worth of stockOn the 16th of May, Jeremiah Bickham sold around 50k shares on-market at roughly US$70.09 per share. This transaction amounted to 96% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Jeremiah's only on-market trade for the last 12 months.
Major Estimate Revision • May 09Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$1.12 to US$0.858 per share. Revenue forecast steady at US$3.08b. Net income forecast to grow 524% next year vs 12% growth forecast for Insurance industry in the US. Consensus price target of US$75.90 unchanged from last update. Share price rose 8.2% to US$70.13 over the past week.
Declared Dividend • May 05First quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 13th May 2025 Payment date: 27th May 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 108%. Cash payout ratio: 29%.
New Risk • May 02New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.9% Last year net profit margin: 3.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin).
Reported Earnings • May 02First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2025 results: US$0.22 loss per share (down from US$0.14 profit in 1Q 2024). Revenue: US$690.2m (up 28% from 1Q 2024). Net loss: US$4.39m (down 127% from profit in 1Q 2024). Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
공시 • May 02+ 1 more updateRyan Specialty Holdings, Inc. Declares Regular Quarterly Dividend, Payable on May 27, 2025On May 1, 2025, the board of directors of Ryan Specialty Holdings, Inc. declared a regular quarterly dividend of $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on May 27, 2025 to stockholders of record as of the close of business on May 13, 2025. A portion of the dividend, $0.05 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company's Class A common stock and the holders of the LLC Common Units.
공시 • Apr 07Ryan Specialty Holdings, Inc., Annual General Meeting, May 30, 2025Ryan Specialty Holdings, Inc., Annual General Meeting, May 30, 2025.
공시 • Apr 04Ryan Specialty Holdings, Inc. to Report Q1, 2025 Results on May 01, 2025Ryan Specialty Holdings, Inc. announced that they will report Q1, 2025 results After-Market on May 01, 2025
공시 • Mar 28Ryan Specialty Holdings, Inc. Appoints Stephen P. Keogh as Chief Operating Officer, Effective May 1, 2025On March 27, 2025, Ryan Specialty Holdings, Inc. announced the appointment of Mr. Stephen P. Keogh to the position of Chief Operating Officer of the Company, effective May 1, 2025. Stephen P. Keogh, age 58, was most recently Senior Advisor to the Office of President, Aon plc, a position he held from October 2021 until his retirement in September 2022. Prior to that, commencing June 2019, Mr. Keogh was President of Aon plc's Commercial Risk Solutions, the global risk management business of Aon. Mr. Keogh brings in excess of thirty- two years of experience at Aon, where he held positions in operations, finance and accounting, technology, human resources and executive management. Mr. Keogh is a member of the Board of Trustees of the Illinois Institute of Chicago and earned a Bachelor’s degree from the University of Illinois.
Recent Insider Transactions Derivative • Mar 18Executive VP & Chief Revenue Officer exercised options and sold US$2.1m worth of stockOn the 14th of March, Brendan Mulshine exercised options to acquire 30k shares at no cost and sold these for an average price of US$69.30 per share. This trade did not impact their existing holding. Since June 2024, Brendan's direct individual holding has decreased from 76.50k shares to 75.82k. Company insiders have collectively sold US$179m more than they bought, via options and on-market transactions in the last 12 months.
Major Estimate Revision • Feb 28Consensus EPS estimates fall by 12%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from US$3.02b to US$3.05b. EPS estimate fell from US$1.44 to US$1.27 per share. Net income forecast to grow 212% next year vs 9.4% growth forecast for Insurance industry in the US. Consensus price target broadly unchanged at US$75.60. Share price rose 2.1% to US$70.03 over the past week.
Declared Dividend • Feb 25Fourth quarter dividend of US$0.12 announcedShareholders will receive a dividend of US$0.12. Ex-date: 4th March 2025 Payment date: 18th March 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 56%. Cash payout ratio: 27%.
New Risk • Feb 24New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 33% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Significant insider selling over the past 3 months (US$34m sold).
공시 • Feb 21+ 1 more updateRyan Specialty Holdings, Inc. Declares Regular Quarterly Dividend on Outstanding Class A Common Stock, Payable on March 18, 2025On February 20, 2025, Ryan Specialty Holdings, Inc. declared and increased the Company's regular quarterly dividend by 9.1% to $0.12 per share on the outstanding Class A common stock. The regular quarterly dividend will be payable on March 18, 2025 to stockholders of record as of the close of business on March 4, 2025. A portion of the dividend, $0.05 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company's Class A common stock and the holders of the LLC Common Units.
공시 • Feb 04Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others for approximately $530 million on January 7, 2025. The upfront cash consideration is exclusive of VSIC and any earnout consideration. Velocity generated approximately $81 million of operating revenue for the 12 months ended December 31, 2024. The acquisition of Velocity is expected to close in early 2025. Andrew Jamieson of Debevoise & Plimpton LLP acted as legal advisor to Oaktree and Velocity Risk. Howden Tiger Capital Markets & Advisory, LLC acted as financial advisor to Oaktree and Velocity Risk. Insurance Advisory Partners LLC acted as financial advisor to Oaktree and Velocity Risk. Sidley Austin LLP acted as legal advisor to Ryan Specialty. J.P. Morgan Securities LLC acted as financial advisor to Ryan Specialty. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others on February 3, 2025.
Recent Insider Transactions • Jan 16Director recently sold US$6.5m worth of stockOn the 15th of January, Nicholas Cortezi sold around 99k shares on-market at roughly US$65.50 per share. This transaction amounted to 28% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth US$7.0m. Insiders have been net sellers, collectively disposing of US$25m more than they bought in the last 12 months.
공시 • Jan 10Ryan Specialty Holdings, Inc. to Report Q4, 2024 Results on Feb 20, 2025Ryan Specialty Holdings, Inc. announced that they will report Q4, 2024 results After-Market on Feb 20, 2025
공시 • Jan 09Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire Velocity Risk Underwriters, LLC from Velocity Holdco, LLC for approximately $530 million.Ryan Specialty Holdings, Inc. (NYSE:RYAN) signed a definitive agreement to acquire Velocity Risk Underwriters, LLC from Oaktree Capital Management, L.P. and others for approximately $530 million on January 7, 2025. The upfront cash consideration is exclusive of VSIC and any earnout consideration. Velocity generated approximately $81 million of operating revenue for the 12 months ended December 31, 2024. The acquisition of Velocity is expected to close in early 2025. Andrew Jamieson of Debevoise & Plimpton LLP acted as legal advisor to Oaktree and Velocity Risk. Howden Tiger Capital Markets & Advisory, LLC acted as financial advisor to Oaktree and Velocity Risk. Insurance Advisory Partners LLC acted as financial advisor to Oaktree and Velocity Risk. Sidley Austin LLP acted as legal advisor to Ryan Specialty. J.P. Morgan Securities LLC acted as financial advisor to Ryan Specialty.
Recent Insider Transactions • Dec 18Director recently sold US$7.0m worth of stockOn the 17th of December, Nicholas Cortezi sold around 105k shares on-market at roughly US$66.54 per share. This transaction amounted to 21% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$18m more than they bought in the last 12 months.
Recent Insider Transactions Derivative • Nov 14Executive VP exercised options and sold US$1.1m worth of stockOn the 8th of November, Mark Katz exercised options to acquire 15k shares at no cost and sold these for an average price of US$71.39 per share. This trade did not impact their existing holding. Since March 2024, Mark's direct individual holding has increased from 13.26k shares to 14.14k. Company insiders have collectively sold US$144m more than they bought, via options and on-market transactions in the last 12 months.
공시 • Nov 05Ryan Specialty Holdings, Inc. acquired Innovisk Capital Partners LLP from BHMS Investments, LP and ABRY Partners, LLC.Ryan Specialty Holdings, Inc. announced the acquisition of Innovisk Capital Partners LLP from BHMS Investments, LP and ABRY Partners, LLC on October 30, 2024. The acquisition is expected to close early next month. Ardea Partners International Llp acted as financial advisor to Innovisk Capital Partners LLP. Kirkland & Ellis LLP and Hill Dickinson LLP acted as legal advisor to Innovisk Capital Partners LLP, BHMS Investments, LP and ABRY Partners, LLC. Ryan Specialty Holdings, Inc. completed the acquisition of Innovisk Capital Partners LLP from BHMS Investments, LP and ABRY Partners, LLC on November 4, 2024.
공시 • Nov 02+ 1 more updateRyan Specialty Holdings, Inc. Maintains Earnings Guidance for the Full Year 2024Ryan Specialty Holdings, Inc. maintained earnings guidance for the full year 2024. The Company is maintaining its full year 2024 outlook for Organic Revenue Growth Rate is between 13.0% – 14.0%.
Reported Earnings • Nov 01Third quarter 2024 earnings: EPS misses analyst expectationsThird quarter 2024 results: EPS: US$0.15 (up from US$0.044 loss in 3Q 2023). Revenue: US$588.1m (up 21% from 3Q 2023). Net income: US$28.6m (up US$33.8m from 3Q 2023). Profit margin: 4.9% (up from net loss in 3Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 24%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
공시 • Oct 03+ 1 more updateRyan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Assets of Geo Underwriting Services Limited.Ryan Specialty Holdings, Inc. (NYSE:RYAN) agreed to acquire Assets of Geo Underwriting Services Limited on September 3, 2024. The transaction is expected to close during the third quarter of this year. Walter Craft will be appointed as Managing Director of Ryan Financial Lines and Benelux and DACH and will join the Ryan Financial Lines Executive Committee. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Assets of Geo Underwriting Services Limited on October 1, 2024.
공시 • Sep 17Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Property and Casualty MGUs of Ethos Specialty Insurance, LLC from Ethos Specialty Insurance Services LLC.Ryan Specialty Holdings, Inc. (NYSE:RYAN) agreed to acquire Property and Casualty MGUs of Ethos Specialty Insurance, LLC from Ethos Specialty Insurance Services LLC on September 3, 2024. Ethos P&C generated approximately $11 million of operating revenue for the 12 months ended June 30, 2024. The acquisition is expected to close during September 2024. Evercore served as exclusive financial advisor to Ascot. Ryan Specialty Holdings, Inc. (NYSE:RYAN) completed the acquisition of Property and Casualty MGUs of Ethos Specialty Insurance, LLC from Ethos Specialty Insurance Services LLC on September 16, 2024.
Recent Insider Transactions • Sep 02Director recently sold US$1.5m worth of stockOn the 29th of August, Nicholas Cortezi sold around 24k shares on-market at roughly US$64.59 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth US$6.8m. Insiders have been net sellers, collectively disposing of US$10m more than they bought in the last 12 months.
Recent Insider Transactions • Aug 21Director recently sold US$1.1m worth of stockOn the 19th of August, Nicholas Cortezi sold around 17k shares on-market at roughly US$64.69 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$1.6m more than they bought in the last 12 months.
새로운 내러티브 • Aug 21Expanding Broker Networks And Tech Innovation Fuel Revenue And Margin Growth Acquiring U.S. Assure enhances Ryan Specialty's broker network and market reach, aligning with growth sectors like construction, promising revenue increases.
Recent Insider Transactions Derivative • Aug 12President & Director exercised options and sold US$125m worth of stockOn the 9th of August, Timothy Turner exercised options to acquire 2m shares at no cost and sold these for an average price of US$62.45 per share. This trade did not impact their existing holding. Since March 2024, Timothy's direct individual holding has increased from 11.04k shares to 15.07k. Company insiders have collectively sold US$132m more than they bought, via options and on-market transactions in the last 12 months.
